Ping An Biomedical Co

Ping An Biomedical Co ROE

The Return on Equity (ROE) of Ping An Biomedical Co (PASW) as of Nov 20, 2026 is 17.87 %. In the previous year, Return on Equity (ROE) was 16.96 % — a change of 5.33% (higher).

ROE

17.87 %

YoY

5.33%

Last updated:

In 2024, Ping An Biomedical Co's return on equity (ROE) was 17.87 %, a 5.33% increase from the 16.96 % ROE in the previous year.

The Ping An Biomedical Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2022
157.12 CNY
Jan 1, 2023
16.96 CNY
Jan 1, 2024
17.87 CNY
The Ping An Biomedical Co ROE history
YEARROEYoY
17.87 %+5.33%
16.96 %-89.20%
157.12 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ping An Biomedical Co Stock analysis

What does Ping An Biomedical Co do? Majestic Ideal Holdings Ltd. generates revenue by providing supply chain management services within the apparel industry. The firm delivers one-stop solutions to customers for a broad range of yarn products, textiles, and finished garments. These services cover functions within the supply chain, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The company employs 7 full-time employees to support these operations. The business is organized into two distinct segments. The Sales of Yarns segment is mainly engaged in the provision of yarn products, textiles, and other products. The Sales of Finished Garments segment is mainly engaged in the provision of finished garments. Through these segments, the firm provides end-to-end supply chain solutions to its clients. Ping An Biomedical Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding Ping An Biomedical Co's Return on Equity (ROE)

Ping An Biomedical Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Ping An Biomedical Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Ping An Biomedical Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Ping An Biomedical Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Ping An Biomedical Co stock

Return on Equity (ROE) of Ping An Biomedical Co is 17.87 % in 2024.

Return on Equity (ROE) of Ping An Biomedical Co changed from 16.96 % to 17.87 %, representing a 5.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Ping An Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Ping An Biomedical Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Ping An Biomedical Co

All Key Metrics — Ping An Biomedical Co